Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00555152

Completed

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

HER2/Neu Positive | Ductal Breast Carcinoma In Situ
NCT03666819

Withdrawn

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
NCT07602907

Not yet recruiting

Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial

Advanced Breast Cancer | HER2-negative Breast Cancer
NCT04293146

Active, not recruiting

Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC (OPBC-02PREPEC)

Breast Reconstruction | Implant-Based Breast Reconstruction (IBBR)
NCT03317405

Active, not recruiting

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

Breast Carcinoma In Situ | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7
NCT03523195

Completed

Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors (PACT)

Sedentary Lifestyle | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8
NCT07441512

Not yet recruiting

A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation

TNBC - Triple-Negative Breast Cancer | TNBC
NCT06954623

Recruiting

Partial Breast Re-irradiation for Breast Cancer (BREAST)

Breast Cancers
NCT06875128

Recruiting

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease (DELUMA)

Metastatic Breast Cancer in the Liver
NCT06693037

Recruiting

Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy (nonPHER)

HER2-positive Breast Cancer
NCT06548919

Recruiting

Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer

Advanced Breast Cancer | ESR1 Gene Mutation
NCT06439771

Recruiting

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC

Locally Advanced or Metastatic Breast Cancer
NCT06412133

Not yet recruiting

Conversations in Light and Shadow: Assessing Phototherapy's Impact on Breast Cancer Patients

Breast Cancer | Randomized Controlled Trial | Breast Cancer Female
NCT06396754

Not yet recruiting

Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC (AIDOBE)

Triple Negative Breast Cancer
NCT06340230

Recruiting

SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer

HR Positive/HER2 Low Breast Cancer
NCT06185946

Recruiting

Evaluation of Different Imaging Modalities in Regional Lymph Nodes Staging in Patients With Breast Cancer

Breast Carcinoma Metastatic in Lymph Node
NCT05907681

Recruiting

Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

Breast Cancer | Metastatic Breast Cancer | Radiation Therapy Complication
NCT05744687

Recruiting

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

Locally Advanced or Metastatic Breast Cancer
NCT05373628

Not yet recruiting

Study on the Correlation Between the Quantitative Parameters of Mr Mean Cell Size Imaging and the Histopathological Characteristics of Breast Cancer (OGSE)

Breast Carcinoma; Magnetic Resonance Imaging；OGSE
NCT05303038

Recruiting

Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy (Castle06(BC))

Metastatic Breast Cancer in the Liver
NCT05000736

Recruiting

Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC (CAPACITY)

Hormone Receptor Positive Advanced Breast Cancer
NCT04278469

Recruiting

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Early Hormone Receptor-positive Breast Cancer
NCT03870919

Active, not recruiting

Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients (PALATINE)

Surgery | Breast Cancer Stage IV | Radiotherapy
NCT07426952

Suspended

Weight Management After Cancer for Survivors in Rural Communities (WeCan-Rural)

Breast Cancer | Weight Management | Breast Cancer Survivorship | Cardiovascular (CV) Risk
NCT05296798

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Locally Advanced or Metastatic Breast Cancer
NCT06764186

Active, not recruiting

A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain (CAPItana)

Locally Advanced or Metastatic Breast Cancer
NCT07416500

Completed

BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential

Breast Cancer | Breast Lesions of Uncertain Malignant Potential (B3 Lesions)
NCT03781063

Completed

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Locally Advanced or Metastatic Breast Cancer
NCT06265428

Active, not recruiting

A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

HER2-positive Breast Cancer
NCT03077776

Active, not recruiting

Tracking Triple-negative Breast Cancer Evolution Through Therapy (TRACERX-TNBC)

Triple-Negative Breast Neoplasm
NCT06868758

Active, not recruiting

Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer

Neoadjuvant Therapy | HER2 Positive Breast Carcinoma
NCT03752723

Completed

Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)

Triple Negative Breast Cancer
NCT05754047

Completed

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

HER2 Low Breast Carcinoma
NCT02338349

Completed

A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer

Advanced ER+, HER2-Negative Breast Cancer
NCT02162667

Completed

Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

HER2-positive Carcinoma of Breast
NCT02734615

Terminated

Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

Advanced or Metastatic ER+ Breast Cancer
NCT00496795

Active, not recruiting

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer (DDP)

Stage III Breast Cancer AJCC V7
NCT00810017

Terminated

Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

HER-2 Positive Metastatic Breast Cancer
NCT01923298

Completed

Estradiol Levels in Patients Treated With Estring

Estrogen Levels Among Breast Cancer Patients
NCT01596647

Completed

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

Advanced Solid Tumors, Excluding Breast Cancer
NCT02154776

Completed

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (LeeBLet)

Advanced or Metastatic Breast Cancer
NCT04164615

Unknown

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection

HER-2-positive Advanced Breast Cancer
NCT02672189

Completed

Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms

Breast Cancer Survivors | Climacteric Symptoms
NCT01743560

Completed

An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis (4EVERUK)

Oestrogen Receptor Positive Advanced Breast Cancer
NCT01381874

Completed

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Postmenopausal | Metastatic ER+ Her2- Breast Cancer
NCT00237211

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer
NCT03575624

Completed

Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors

Breast Cancer Female | Survivorship
NCT01689610

Completed

Non-interventional Study With Nab-Paclitaxel (Abraxane®) (NABUCCO)

Metastatic Breast Cancer
NCT03397537

Completed

Neoadjuvant Endocrine Therapy in Breast Cancer

Highly Endocrine Responsive Operable Breast Cancer
NCT00998036

Completed

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

Triple Negative Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations